文献速递遗传性与小管间质肾病肾小球疾病急性肾损伤

IgG4相关肾病与腹膜后纤维化:诊断和治疗进展

IgG4-Related Kidney Disease and IgG4-Related Retroperitoneal Fibrosis: An Update on Diagnosis and Treatment.
PubMed 文献 · Kidney Int Rep · 2026-06-02

本文综述IgG4相关肾病(IgG4-RKD)和IgG4相关腹膜后纤维化(IgG4-RPF)的发病机制、临床谱、诊断与治疗。IgG4-RKD最常见表现为小管间质性肾炎,诊断需结合临床、实验室、影像与组织病理并排除模仿疾病。糖皮质激素为传统一线治疗,B细胞靶向治疗更有效且毒性更低。

要点

  • IgG4-RKD最常见为小管间质性肾炎,也可表现为膜性肾小球肾炎等。
  • 诊断需临床、实验室、影像与病理结合,并排除感染、肿瘤等模仿疾病。
  • 糖皮质激素为传统一线,B细胞靶向治疗更有效且毒性更低。

核心结论

  • IgG4-RKD和IgG4-RPF对IgG4-RD的全身治疗有反应,早期识别和治疗对防止不可逆器官损伤至关重要。

研究设计与样本

  • 本文为综述,总结IgG4-RD、IgG4-RKD和IgG4-RPF的发病机制、临床谱、诊断方法和治疗策略。

主要发现

  • IgG4-RKD最常见表现为小管间质性肾炎(TIN),也可表现为膜性肾小球肾炎(MGN)和急性间质性肾炎(AIN)作为IgG4-TIN的组织学亚型。
  • IgG4-RPF可导致梗阻性肾病,伴或不伴活动性肾实质IgG4-RKD。
  • IgG4-RD组织病理特征包括富含IgG4阳性浆细胞的密集淋巴浆细胞浸润,通常伴有席纹状纤维化。

关键数值与推荐

  • IgG4-RD为临床病理诊断,需结合临床、实验室、影像和组织学表现以识别IgG4-RD特征并排除模仿疾病。
  • IgG4-RKD的重要模仿疾病包括感染、恶性肿瘤、ANCA相关疾病、特发性多中心Castleman病、Rosai-Dorfman-Destombes病和干燥综合征(SjD)。
  • IgG4-RPF的模仿疾病包括淋巴瘤、Erdheim-Chester病和特发性RPF。

临床怎么用

  • 临床应综合临床、实验室、影像和病理进行诊断,注意排除模仿疾病。
  • 糖皮质激素为传统一线治疗,B细胞靶向治疗(如利妥昔单抗、inebilizumab、obexelimab)更有效且毒性更低。
  • 早期识别和治疗对防止不可逆器官损伤至关重要。

局限性

  • 本文为综述,未报告原始研究的具体样本量、效应值或置信区间。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Renal involvement of IgG4-related disease (IgG4-RD), collectively termed IgG4-related kidney disease (IgG4-RKD), most commonly manifests as tubulointerstitial nephritis (TIN) but can also manifest as membranous glomerulonephritis (MGN) and acute interstitial nephritis (AIN) as a histologic subtype of IgG4-related TIN (IgG4-TIN). IgG4-related retroperitoneal fibrosis (IgG4-RPF) can cause obstructive kidney disease with or without active parenchymal IgG4-RKD. IgG4-RD is a clinicopathological diagnosis, requiring correlation of clinical, laboratory, radiological, and histological findings to identify features of IgG4-RD and rule out mimickers. Histopathologic features of IgG4-RD in tissue include a dense lymphoplasmacytic infiltrate rich in IgG4-positive plasma cells, typically accompanied by so-called "storiform" fibrosis. Important mimics of IgG4-RKD include infection, malignancy, antineutrophil cytoplasmic autoantibody (ANCA)-associated disease, idiopathic multicentric Castleman disease, Rosai-Dorfman-Destombes disease and Sjögren Disease (SjD). Mimickers of IgG4-RPF include lymphoma, Erdheim-Chester disease, and idiopathic RPF. IgG4-RKD and IgG4-RPF are responsive to the systemic therapies used for IgG4-RD in general. Corticosteroids are the traditional first line therapy; however, B cell-targeted therapies, including rituximab, inebilizumab, and obexelimab are more potent and less toxic than steroids. Further trials are currently being conducted on newer medications that target signaling pathways and immune cells involved in the pathogenesis of IgG4-RD. Early recognition and treatment are critical to prevent irreversible organ damage. This review summarizes the current understanding of the pathogenesis, clinical spectrum, diagnostic approach, and management strategies for IgG4-RD, IgG4-RKD, and IgG4-RPF.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. El-Feghi M, Cornell LD, Geldenhuys L, et al. IgG4-Related Kidney Disease and IgG4-Related Retroperitoneal Fibrosis: An Update on Diagnosis and Treatment. Kidney Int Rep. 2026. PMID: 42440422. doi:10.1016/j.ekir.2026.106630

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。